Peripheral blood CD34+ cell immunomagnetic selection in breast cancer patients: effect on hematopoietic progenitor content and hematologic recovery after high‐dose chemotherapy and autotransplantation
José A. Cancelas(Harvard University), Juan García-López(Shanghai Cell Therapy Research Institute), E. Griera(Shanghai Cell Therapy Research Institute), James Ingles(Shanghai Cell Therapy Research Institute), Carmen Azqueta(Banc de Sang i Teixits), Sergio Querol, Ana Montes(Guy's and St Thomas' NHS Foundation Trust), Javier Jiménez López(Hospital de Sant Pau), J.R. Germà(Hospital Universitari Sant Joan de Reus), Christophe Sola(Inserm), M Picón(Shanghai Cell Therapy Research Institute), B Amill(Centro de Pesquisas Oncológicas)
Cited by 22
Related Papers
Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology
|BMC Microbiology|2006|1k
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
|The Lancet Oncology|2021|614
Connexin-43 prevents hematopoietic stem cell senescence through transfer of reactive oxygen species to bone marrow stromal cells
|Proceedings of the National Academy of Sciences|2012|154
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor
|Gynecologic Oncology|2019|104
Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes
|British Journal of Cancer|2022|89